Tan et al. reported that PSMB2 knockdown inhibits HCC proliferation, invasion, and tumorigenesis (Tan et al., 2018), whereas Niu et al. reported that TNFAIP6 is involved in inflammatory and immune response pathways (Niu et al., 2021). The gene discussed is PSMB2; the disease is hepatocellular carcinoma.